title: Cardiac diastolic function in pediatric patients receiving doxorubicin.
abstract: The purpose of the study was to compare systolic and diastolic function in pediatric patients treated with doxorubicin. Left ventricular function was evaluated in 61 children prior to and following chemotherapy. None had clinical evidence of cardiac decompensation prior to treatment. All received relatively low cumulative doses of doxorubicin; the majority received the drug by continuous infusion. Systolic function was estimated using fractional shortening; diastolic function was estimated using A wave velocity, E wave velocity, E to A ratio, and deceleration time. There was a small but significant decline in systolic cardiac function as estimated from changes in fractional shortening that could not be appreciated in any of the measured parameters of diastolic function. A variety of reasons that could be responsible for the absence of significant changes in diastolic function are discussed. For the present, estimations of systolic function are preferred over the studied parameters of diastolic function in the evaluation of cardiac status in pediatric patients receiving doxorubicin containing regimens.
authors.affiliation: Department of Medical Specialties, University of Texas M. D. Anderson Cancer Center, Houston 77030.
authors.forename: M S
authors.initials: MS
authors.lastname: Ewer
authors.forename: M K
authors.initials: MK
authors.lastname: Ali
authors.forename: H R
authors.initials: HR
authors.lastname: Gibbs
authors.forename: J
authors.initials: J
authors.lastname: Swafford
authors.forename: K L
authors.initials: KL
authors.lastname: Graff
authors.forename: A
authors.initials: A
authors.lastname: Cangir
authors.forename: N
authors.initials: N
authors.lastname: Jaffe
authors.forename: M K
authors.initials: MK
authors.lastname: Thapar
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003971:Diastole / Q000187:drug effects*; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006334:Heart Function Tests; D006801:Humans; D007223:Infant; D008297:Male; D009369:Neoplasms / Q000188:drug therapy; D012189:Retrospective Studies; D013599:Systole / Q000187:drug effects
chemical_list: D004317:Doxorubicin